Within NSCLC, mutations in KEAP1 occur primarily in AC and mutations in NRF2 occur primarily in SCC (Singh et al, 2006; Shibata et al, 2008b; Hayes and McMahon, 2009; Kim et al, 2010). Here, KEAP1 is linked to non-small cell lung carcinoma.